Parameters |
Experimental group |
Control |
ZnO-NPs |
WBC
109 /l |
14.44 ± 1.82 |
13.35 ± 0.82 |
RBC
1012/l |
6.77 ± 0.11 |
6.812 ± 0.24 |
Hematocrit
% |
34.06 ± 0.66 |
34.42 ± 1.33 |
Hemoglobin
g/dl |
12.44 ± 0.43 |
12.22 ± 0.29 |
Platlets
109/l |
603.8 ± 87.90 |
584.2 ± 88.92 |
AST
U/l |
38.85 ± 5.19 |
116.9 ± 24.83* |
ALT
U/l |
12.6 ± 1.92 |
23.27 ± 2.48* |
LDH
U/l |
586.88 ± 183.86 |
270.37 ± 63.21 |
Creatinine
mg/dl |
0.67 ± 0.06 |
0.67 ± 0.057 |
Uric acid
mg/dl |
6.34 ± 0.38 |
7.01 ± 0.40 |
Glucose
mg/dl |
159.27 ± 10.30 |
139.56 ± 16.23 |
|
Data represent the means ± SEM of 6 animals per group. *p<0.05, compared to control |
Table 4: Effects of ZnO-NPs treatment on the hematological and biochemical
parameters in rats. |